N-Acetylcysteine for Health & Longevity - Quick Reference Sheet

N-Acetylcysteine for Health & Longevity

Created on 07/07/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

NAC supplies the raw material cells use to rebuild glutathione, their main internal defense, reliably raising it and lowering signs of cellular stress. Support is solid for fewer long-term lung flare-ups, moderate for certain brain-chemistry conditions, and weak or conflicting elsewhere. Low-risk and inexpensive, with benefits largest for those starting with depleted defenses. (Full Review)

Protocol

Dose
600–1,800 mg/day
Lower end for general antioxidant support; ≥1,200 mg/day for respiratory or clinical targets
Frequency
1–3× daily
Splitting the total into 2–3 doses keeps blood levels steadier and improves tolerability
Titration
Start 600 mg
Begin low with a meal and increase only if tolerated to limit digestive upset
Time to effect
Biochemical
Days–weeks
Rising glutathione and falling oxidative markers
Clinical benefit
Weeks–months
Respiratory, metabolic, or behavioral effects with consistent use

Benefits

Contraindications
  • Active peptic ulcer disease
  • Poorly controlled asthma
  • Prior anaphylactoid reaction to NAC
  • Nitrate therapy
  • Bleeding disorder
  • Surgery within 1–2 weeks
  • Active or high-risk cancer
  • Pregnancy (general supplementation)
Key Interactions
  • Blood thinners & antiplatelets (warfarin, aspirin, clopidogrel)
  • Antihypertensives (ACE inhibitors, calcium-channel blockers)
  • Activated charcoal
  • Vasodilatory OTC products (high-dose L-arginine)
  • Chemotherapy or radiotherapy
  • Copper & zinc (chronic high-dose use)

Risk & Side Effects

  • High: Gastrointestinal distress
  • Medium: Anaphylactoid reactions; airway irritation & bronchospasm
  • Low: Blunting of exercise-training adaptations; mild antiplatelet & blood-pressure effects
  • Speculative: Possible promotion of existing tumors; reductive stress from chronic high doses

Monitoring

Marker Target Why
Glutathione (whole-blood/RBC) Upper half of reference range Direct readout of the pathway NAC targets
hs-CRP Below 1.0 mg/L Tracks systemic inflammation NAC may lower
Homocysteine 5–7 µmol/L General oxidative/methylation status; context for redox balance
Fasting insulin 2–5 µIU/mL Captures the insulin-sensitivity benefit seen in metabolic studies
ALT and AST ~10–26 U/L each Safety and organ-health baseline
Copper and zinc Mid-range, balanced ratio Guards against depletion from NAC's mineral binding

Cadence: Baseline, again at 8–12 weeks, then every 6–12 months during continued use

Qualitative Assessment

  • Energy levels and exercise capacity across the day
  • Respiratory comfort and ease of mucus clearance, if that was a goal
  • Cognitive clarity and mood stability
  • Frequency of minor infections or illness
  • Overall tolerability, especially absence of persistent digestive upset